Stryker Expands Reach Throughout Trauma Segment Executive Insights Industry Voices We spoke to Tim Lanier, Stryker’s President, Trauma and Extremities, about innovation and expansion in both core trauma and foot and ankle. Sep 26, 2024
3 Trends We’re Watching in a Changing Spine Market Market Analysis The Numbers Consolidation, enabling technology and implant breakthroughs are creating long term change in the spine market. Sep 19, 2024
Busiest M&A Companies Focused on Digital Assets Chart of the Month The Numbers The top ten most acquisitive orthopedic companies since 2016 are more focused on technology than the rest of the market. Sep 11, 2024
Orthopedic Executives Reflect on 2024’s First Half Executive Insights Industry Voices Leaders from the top orthopedic companies reflect on enabling technology, international opportunities and market conditions in 1H24. Sep 04, 2024
The State of the Trauma Market Videos This video delves into the state of the trauma market, exploring the trends shaping its trajectory to over $10 billion in sales by 2027. Sep 02, 2024
Medtronic’s Winning Formula Driving Above Market Growth Company Revenue The Numbers The company drove mid-single-digit sales growth in the first quarter of its 2025 fiscal year driven by pull through from the AiBLE ecosystem. Aug 22, 2024
Enovis Aims to Change the Game for Shoulder Surgeons Executive Insights Industry Voices We spoke to Louie Vogt, Enovis' Group President of Reconstructive, to learn about the company's strategy in the fast-growing shoulder market. Aug 21, 2024
Treace Medical Broadens Presence in Bunion Market Company Revenue The Numbers The company grew in the mid-single digits during the second quarter of 2024 as it looks to expand its presence in the bunion market. Aug 16, 2024
Orthopedic Growth Rate Slows, Market Remains Robust Chart of the Month The Numbers While orthopedic growth rates slowed in the first half of 2024, the market's volume and demand remain healthy. Aug 15, 2024
SI-BONE Sees Strong Demand Across Markets, Raises Guidance Company Revenue The Numbers The company grew 20% in the second quarter of 2024 driven by an expanding portfolio and active surgeon base. Aug 15, 2024